AC710 - CAS# 1351522-04-7 aempferol mutation of Trp741 to Cys)

mutation of Trp741 to Cys)

CDK8/19i maintains pluripotency of mouse PSCs in culture

Smiles: OC1C(Br)=CC(=CC=1Br)C1=NOC(=N1)C(=O)NCC1C=CC(=CC=1)OC1C=CC=CC=1

primarily as a preventative to reduce the frequency of recurrent migraine headaches

In the United States

AC710 - CAS# 1351522-04-7 aempferol mutation of Trp741 to Cys)AC710 is a potent, orally active, and selective platelet derived growth factor receptor family kinase inhibitor with potential anticancer activity. Its IC50 values are 1. 2, 2, 7. 7 and 10. 5 nM for KIT, FLT3, PDGFR and CSF1R respectively; Kd = 1. 3 nM for PDGFR.. AC710 causes tumor regression of leukemia cell xenografts in mice. AC710 also reduces joint swelling and inflammation in a mouse model of collagen induced arthritis. AC710 is now a